File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1287/mnsc.1110.1380
- Scopus: eid_2-s2.0-80054050134
- WOS: WOS:000295926500012
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Intellectual capital and financing decisions: Evidence from the U.S. patent data
Title | Intellectual capital and financing decisions: Evidence from the U.S. patent data | ||||
---|---|---|---|---|---|
Authors | |||||
Keywords | Capital structure Default Intellectual capital Patent-based metrics R&D-based metrics | ||||
Issue Date | 2011 | ||||
Publisher | INFORMS. The Journal's web site is located at http://mansci.pubs.informs.org | ||||
Citation | Management Science, 2011, v. 57 n. 10, p. 1861-1878 How to Cite? | ||||
Abstract | This paper develops a real options model to understand two distinct roles played by intellectual capital in corporate financing decisions. Whereas limiting a firm's debt capacity because of its low liquidation value, intellectual capital enhances a firm's debt capacity through its positive impact on earnings. Our model shows that the former dominates or is dominated by the latter, depending on whether the rate of dissipation of intellectual capital upon default is larger or smaller than a critical level, respectively. Using patent-based and research-and-development-based variables as proxies for intellectual capital, we find robust evidence that the relation between intellectual capital and leverage is positive. Specifically, a one-standard-deviation increase in the level of a firm's intellectual capital is associated with an increase of 6.6% to 21.1% in its market leverage. We further find this positive relation to be stronger for biotechnology firms. © 2011 INFORMS. | ||||
Persistent Identifier | http://hdl.handle.net/10722/144603 | ||||
ISSN | 2023 Impact Factor: 4.6 2023 SCImago Journal Rankings: 5.438 | ||||
ISI Accession Number ID |
Funding Information: An earlier version of this paper circulated under the title "Intellectual Capital and Financing Decisions: Evidence from the U.S. Biotech Firms." The authors are extremely grateful to Simon Gervais (the associate editor) and three anonymous referees for many constructive comments that have greatly improved the paper. The authors thank Hongbin Cai, Bradford Cornell, Michael Darby, Vidhan Goyal, David Hsieh, David K. Levine, Neal Stoughton, Wei Xiong (the department editor), participants at the University of New South Wales, and the 2001 Capital Structure Conference at Rutgers for helpful comments. The authors thank Yong Wei and Jingyi Liu for their excellent research assistance. Financial support from the Research Grants Commission of the Hong Kong Special Administrative Region, China (Projects HKU7472/06H, HKU727107H, and HKU748910H) is gratefully acknowledged. All errors remain the authors' responsibility. | ||||
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Liu, Q | en_HK |
dc.contributor.author | Wong, KP | en_HK |
dc.date.accessioned | 2012-02-03T06:15:22Z | - |
dc.date.available | 2012-02-03T06:15:22Z | - |
dc.date.issued | 2011 | en_HK |
dc.identifier.citation | Management Science, 2011, v. 57 n. 10, p. 1861-1878 | en_HK |
dc.identifier.issn | 0025-1909 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/144603 | - |
dc.description.abstract | This paper develops a real options model to understand two distinct roles played by intellectual capital in corporate financing decisions. Whereas limiting a firm's debt capacity because of its low liquidation value, intellectual capital enhances a firm's debt capacity through its positive impact on earnings. Our model shows that the former dominates or is dominated by the latter, depending on whether the rate of dissipation of intellectual capital upon default is larger or smaller than a critical level, respectively. Using patent-based and research-and-development-based variables as proxies for intellectual capital, we find robust evidence that the relation between intellectual capital and leverage is positive. Specifically, a one-standard-deviation increase in the level of a firm's intellectual capital is associated with an increase of 6.6% to 21.1% in its market leverage. We further find this positive relation to be stronger for biotechnology firms. © 2011 INFORMS. | en_HK |
dc.language | eng | en_US |
dc.publisher | INFORMS. The Journal's web site is located at http://mansci.pubs.informs.org | en_HK |
dc.relation.ispartof | Management Science | en_HK |
dc.subject | Capital structure | en_HK |
dc.subject | Default | en_HK |
dc.subject | Intellectual capital | en_HK |
dc.subject | Patent-based metrics | en_HK |
dc.subject | R&D-based metrics | en_HK |
dc.title | Intellectual capital and financing decisions: Evidence from the U.S. patent data | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Liu, Q: qliu@hku.hk | en_HK |
dc.identifier.email | Wong, KP: kpwongc@hkucc.hku.hk | en_HK |
dc.identifier.authority | Liu, Q=rp01078 | en_HK |
dc.identifier.authority | Wong, KP=rp01112 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1287/mnsc.1110.1380 | en_HK |
dc.identifier.scopus | eid_2-s2.0-80054050134 | en_HK |
dc.identifier.hkuros | 198178 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-80054050134&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 57 | en_HK |
dc.identifier.issue | 10 | en_HK |
dc.identifier.spage | 1861 | en_HK |
dc.identifier.epage | 1878 | en_HK |
dc.identifier.eissn | 1526-5501 | - |
dc.identifier.isi | WOS:000295926500012 | - |
dc.publisher.place | United States | en_HK |
dc.identifier.scopusauthorid | Liu, Q=55429572300 | en_HK |
dc.identifier.scopusauthorid | Wong, KP=7404759417 | en_HK |
dc.identifier.issnl | 0025-1909 | - |